Dietmar P Rabussay

CIK 1260935 · View on SEC EDGAR ↗

Insider

First SEC filing: March 1, 2005 · Latest: March 1, 2005

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 6 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

6 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Nov. 11, 2004 INO S 250 $3.41 $852 17,386 Direct -1.42% Disposed -99.3% (price as of 2026-08-21)
Sept. 16, 2004 INO P 514 $8.80 $4,523 514 Direct Acquired -99.7% (price as of 2026-08-21)
Sept. 16, 2004 INO P 1 $5882.35 $5,882 1 Direct Acquired -100.0% (price as of 2026-08-21)
Dec. 22, 2003 INO S 20,000 $1.16 $23,200 70,362 Direct -22.13% Disposed -99.4% (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
March 8, 2007 INO Common Stock Option Common Stock (25,000) $3.16 March 8, 2017 25,000 Acquired
March 8, 2006 INO Inovio Biomedical Corporation Inovio Biomedical Corporation Common Stock (35,000) $2.89 March 8, 2016 35,000 Acquired
Feb. 25, 2005 INO Genetronics Biomedical Corporation Common Stock Genetronics Biomedical Corporation Common Stock (10,000) $4.46 Feb. 24, 2015 10,000 Acquired
Sept. 16, 2004 INO Genetronics Biomedical Corporation Common Stock Warrants Genetronics Biomedical Corporation Common Stock $8.80 May 10, 2009 514 Acquired
Aug. 8, 2003 INO Common Stock Common Stock (79,750) $0.63 Aug. 7, 2013 79,750 Acquired
July 7, 2003 INO Warrants Common Stock (25,532) $0.65 July 7, 2003 25,532 Disposed

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

INO

Vice President, Research and Development
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2007 $185,391 $63,927 $5,200 $254,518

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.